← Back to Clinical Trials
Recruiting NCT07098611

NCT07098611 A New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07098611
Status Recruiting
Phase
Sponsor Medipol University
Condition Ventilator Weaning
Study Type OBSERVATIONAL
Enrollment 470 participants
Start Date 2025-06-15
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 89 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 470 participants in total. It began in 2025-06-15 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Liberation from mechanical ventilation involves three steps: weaning, readiness assessment, and extubation. Readiness is determined using clinical criteria such as improvement of the underlying condition, hemodynamic stability, and adequate respiratory effort. Successful extubation is defined as not requiring invasive support within 48 hours. Due to the complexity of ICU patients, various clinical parameters and multi-component scores have been developed to predict extubation success. This study aims to develop and evaluate a multi-component score, the Readiness for EXtubation score (REXs), to predict extubation readiness in ICU patients under invasive mechanical ventilation.

Eligibility Criteria

Inclusion Criteria: \- Patients who are in the weaning process from mechanical ventilation after being connected to invasive mechanical ventilation in the intensive care unit. Exclusion Criteria: * Patients without legal guardian consent. * Tracheostomized patients. * Patients enrolled in other studies. * Individuals with diaphragmatic pacers. * Pregnant patients.

Contact & Investigator

Central Contact

Berkan Basançelebi

✉ berkan.basancelebi@medipol.edu.tr

📞 +90 444 8 544

Frequently Asked Questions

Who can join the NCT07098611 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Ventilator Weaning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07098611 currently recruiting?

Yes, NCT07098611 is actively recruiting participants. Contact the research team at berkan.basancelebi@medipol.edu.tr for enrollment information.

Where is the NCT07098611 trial being conducted?

This trial is being conducted at Punta Arenas, Chile, Cairo, Egypt, Tehran, Iran, Naples, Italy and 3 additional locations.

Who is sponsoring the NCT07098611 clinical trial?

NCT07098611 is sponsored by Medipol University. The trial plans to enroll 470 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology